Microbiome & Chronic Diseases

Evidence Based Medicine
Sign in

Disease ⇒ CVD {40000183}

Record Keys

Parent:[  ]


Initialisation date:
Other Terms:
Cardiovascular Disease

Meta Information

MedDra ID:[  ]
MedDra Level:[  ]
ICD:[  ]
Zone:[  ]
Mechanism:[  ]


[  ]

References Notes

[  ]

Shared Reference Notes

  • [1.2
    - Choline > Elevated plasma levels of the gut microbe-dependent metabolite TMAO > predict incident risk for CVD development independent of traditional risk factors.
  • [1.1
    - Meat-based diet > L-carnitine > Gut microbial transformation >intermediate γ-butyrobetaine (γBB) > trimethylamine (TMA) > TMAO
    - Plasma γBB levels in individuals > strongly associated with incident CVD event risks.
    - Emergencia timonensis > metabolize γBB into TMA > complete the carnitine → γBB → TMA transformation > elevate TMAO levels > enhance thrombosis
  • [1.3
    - Fish > rich in preformed TMAO > greatest impact on circulating TMAO concentrations; however, fish intake is associated with decreased risk of cardiovascular disease
  • [1.4
    - Prob+BBR superior to BBR or Prob alone in improving postprandial total cholesterol (pTC) and low-density lipoprotein cholesterol (pLDLc) levels with decrement of multiple species of postprandial lipidomic metabolites after 3 months follow-up.
    - This effect was linked to the changes of fecal Bifidobacterium breve level responding to BBR alone or Prob+BBR treatment.
    - Four fadD genes encoding long-chain acyl-CoA synthetase > identified in the genome of this B. breve strain, and transcriptionally activated by BBR.
    - The activation of fadD by BBR could enhance FFA import and mobilization in B. breve and diliminish the intraluminal lipids for absorption to mediate the effect of Prob+BBR on PL.